Rivaroxaban (Xarelto, BAY59-7939)
11702b
Phase 3 small_molecule completed
Quick answer
Rivaroxaban (Xarelto, BAY59-7939) for Pulmonary Embolism is a Phase 3 program (small_molecule) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer HealthCare AG
- Indication
- Pulmonary Embolism
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed